4 ovarian cancer candidates to watch: GSK, Allarity and more
Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, OSE Immunotherapies and others are advancing their own candidates.
4 ovarian cancer candidates to watch: GSK, Allarity and more Read More »
